Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults

Inclusion Criteria: * Individuals must be between 40-75 years of age with no known medical conditions that, in the investigator's opinion, may interfere with study participation. * Individuals must present with moderate signs of aging * Subject is willing and able to participate in all aspects of the study * Individuals must sign informed consent, photo release consent and confidentiality agreement * Subject eats 1 or less servings of fatty fish per week * Subject has a BMI \> 19 and \< 30 * Subjects who have been on a stable dose of chronic use medications for at least 3 months prior to study participation * Subjects who, in the opinion of the investigator, are free of any medical condition(s) that might affect study measures Exclusion Criteria: * Subject failure to provide informed consent * Individuals that are being treated for cancer or have a history of facial skin cancer on the test areas * Individuals with sunburn, moderate to pronounced suntan, even skin tones, tattoos, scars or other disfiguration, dilated vessels or other conditions on the test area that might influence the test results * Any disease or condition of the skin that the examining investigator deems inappropriate for participation, including rosacea, eczema, psoriasis, and atopic dermatitis * Individuals currently taking medications which in the opinion of the investigators may interfere with the study. This would include but not be limited to routine high dosage use of anti-inflammatory drugs (aspirin, ibuprofen, corticosteroids) immunosuppressive drugs or antihistamine medications (steroid nose drops and/or eye drops are permitted), and insulin, antibiotics or other topical drugs at the test sites. * Individuals with uncontrolled metabolic diseases such as diabetes (Type I and II), hypertension, hyperthyroidism or hypothyroidism, severe chronic asthma, immunological disorders such as HIV positive, AIDS and systemic lupus erythematosus or mastectomy for cancer involving removal of lymph nodes * Subject is taking supplemental oral dietary/nutritional supplements containing more than 800 IU of vitamin D, 200 mg fish oil, 200 mg krill oil, 2 mg total carotenoids (lycopene, lutein, etc.) and/or 5 mg resveratrol within 30 days prior to study product administration * Difficulty in swallowing capsules * Women known to be pregnant, nursing or planning to become pregnant * Individuals participating in other facial clinical studies * Individuals who have routinely used an alpha-hydroxyl-acid (AHA) or a beta-hydroxyl-acid (BHA) containing product within two weeks or Retin-A®, Retin-A Micro®, Renova®, Differin®, Avita®, Tazorac®, or Soriatane® within one month of the study start or have taken Accutane® within one year of the study start. Individuals who have used Retinol in the last six months * Individuals with inflammatory acne lesions (i.e., papules, pustules, cysts, nodules) at the test site * Individuals who have had chemical peels or dermabrasion within the last six months * Individuals with known allergies to fish oil. Individuals currently using topically applied prescription medications where the medication is applied on or near the test site * Individuals who have sun tanned (sun or tanning beds) in the nude within the past 1 year * Excessive alcohol use (\>2 drinks per day) * Subject is a current smoker or quit less than 3 years from screening visit * History of substance abuse * Use of anti-aging treatment skin care products within 30 days of study enrollment and throughout study participation